Gutsy Learning Series

registration is open for the spring 2017 series! 

Are you newly diagnosed or caring for someone who lives with Crohn's disease or ulcerative colitis? Please join us to learn more about emerging treatments and research on these diseases!

Crohn's and Colitis Canada, in partnership with McMaster University, offers you the opportunity to learn more about the latest research in Crohn's disease and ulcerative colitis. The theme of this series will focus on the human microbiome and inflammatory bowel disease. It features an interactive Q&A period with leading Crohn's and colitis renowned medical experts. Registration is FREE!  

Join us in-person at McMaster University or via live webcast from anywhere in Canada! 


Event details

Date: Thursday, April 27, 2017
Time: 6:30-8:30 EST
Location: McMaster University, Michael G. DeGroote Centre for Learning and Discovery (MDCL), Room 2232, 1280 Main Street West, Hamilton, ON L8S 4L8

MAP FOR DIRECTIONS (Visitor parking available- more information). 

Registration opens at 6:00 pm. Refreshments and light snacks will be available. 

Spring 2017 speakers

moayyedi_2015-copy-1.jpg PRESENTER/PANEL: Dr. Paul Moayyedi, BSc, MB, ChB, PhD, MPH, FRCP (London), FRCPC, FACG, AGAF

Dr. Paul Moayyedi is a Professor, Department of Medicine, McMaster University, Director of Clinical Research, Farncombe Family Digestive Health Research Institute, and Director, Division of Gastroenterology at Hamilton Health Sciences.  He has a strong interest in evidence based medicine. He has conducted a number of large randomized controlled trials and epidemiological studies that have evaluated functional and organic disease of the GI tract. He has also published several systematic reviews that have been influential in British, American and Canadian national guidelines. He is the joint Coordinating Editor for the Upper Gastrointestinal and Pancreatic Diseases Cochrane Review Group based at McMaster University and is also Co-Editor-in-Chief of the American Journal of Gastroenterology.
Currently, Dr. Moayyedi leads the IMAGINE Network (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects). He and his team will be developing innovative therapies and novel probiotics for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). 
surette_michael.jpg PRESENTER/PANEL: Dr. Michael Surette, PhD
Dr. Michael Surette is a Professor, Department of Medicine, Principal Investigator, Farncombe Family Digestive Health Research Institute, and has a joint appointment with the Department of Biochemistry and Biomedical Sciences at McMaster University. He is also the Canada Research Chair in Interdisciplinary Microbiome Research.
Dr. Surette's primary foci are on the microbiome in the gastrointestinal and respiratory tracts. He is a researcher for the IMAGINE Network and a member of the team that has carried out a randomized control trial of fecal microbiota transplant (FMT) therapy on patients with ulcerative colitis.   This study found that more patients who had the FMT therapy went into remission compared to those who received a placebo. 
Aida-photo.jpg PRESENTER/PANEL: Aida Fernandes, BSc, MBA 
Aida Fernandes is the Executive Director of the IMAGINE Network – a patient-oriented research initiative in gastrointestinal diseases.  Aida has over 15 years of experience in research administration and strategic partnerships in the health charitable sector.  Aida was the Vice-President of Research and Patient Programs at Crohn’s and Colitis Canada (CCC) where she oversaw the organization’s research, patient education and advocacy programs for the Canadian IBD community.  Prior to her time at CCC, Aida worked at Cystic Fibrosis Canada in several different capacities, including Manager, Chapter Relations; Director, Volunteer & Personnel Resources; and Director, Medical/Scientific and Community Programs.

Aida also has served on a number of governing bodies in the voluntary health sector including: Public Health Agency of Canada’s Respiratory Diseases Surveillance Advisory Committee, HealthPartners Board of Directors, Health Charities’ Coalition of Canada Research Committee, Canadian Genetics Coalition, CIHR’s Institute of Infection and Immunity Institute Advisory Board, and the Canadian Blood Services’ National Liaison Committee. 

Aida holds a bachelor’s degree in Human Biology from the University of Toronto and a Master of Business Administration in Non-Profit Management & Leadership from York University’s Schulich School of Business.
Photo-John-Marshall.jpg PANEL: Dr. John Marshall, MD, MSc, FRCPC, AGAF
Dr. John K. Marshall is a Professor of Medicine at McMaster University and Chief of Service for Gastroenterology at Hamilton Health Sciences.  After completing his B.A. and M.D. at Queen’s University, he undertook his residency training and M.Sc. in Clinical Epidemiology & Biostatistics at McMaster University. He is a Full Member of the Farncombe Family Digestive Health Research Institute. Dr. Marshall is Co-Editor-in-Chief of the Canadian Journal of Gastroenterology and Hepatology. He also serves on Crohn’s and Colitis Canada’s Scientific & Medical Advisory Council.
Professional-Penny-Photo.jpg MODERATOR: Penny Bellhouse, BA
 Penny started working with Crohn’s and Colitis Canada as the Development Coordinator for Southwestern Ontario in April 2011.  She now holds the role of Leadership Gifts Officer. Penny was diagnosed with Crohn’s disease in the fall of 1996 at the age of 13 after several years of experiencing symptoms. She is married, has an adorable little boy named Jacob and is expecting her second child next fall. She is passionate about working at Crohn’s and Colitis Canada and is determined to be part of the generation who finds the cure. 

past video presentations



 Have questions or need more information? Email us at

In Partnership With 



  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 150 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest